TG Therapeutics Inc
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. It provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndro… Read more
TG Therapeutics Inc (TGTX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.038x
Based on the latest financial reports, TG Therapeutics Inc (TGTX) has a cash flow conversion efficiency ratio of -0.038x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-23.15 Million) by net assets ($607.22 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
TG Therapeutics Inc - Cash Flow Conversion Efficiency Trend (1996–2024)
This chart illustrates how TG Therapeutics Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
TG Therapeutics Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of TG Therapeutics Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Samsung SDS Co Ltd
KO:018260
|
0.033x |
|
Petro Rio S.A
PINK:PTRRY
|
0.059x |
|
Avary Holding Shenzhen Co Ltd Class A
SHE:002938
|
0.000x |
|
Lg Electronics Pref
KO:066575
|
0.061x |
|
Grand Canyon Education Inc
NASDAQ:LOPE
|
0.175x |
|
E-L Financial Corp Ltd
PINK:ELFIF
|
0.014x |
|
NIBE Industrier AB ser. B
SW:NIBEB
|
0.065x |
|
Nibe Industrier AB Series B
LSE:0RH0
|
0.019x |
Annual Cash Flow Conversion Efficiency for TG Therapeutics Inc (1996–2024)
The table below shows the annual cash flow conversion efficiency of TG Therapeutics Inc from 1996 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $222.36 Million | $-40.52 Million | -0.182x | +6.90% |
| 2023-12-31 | $160.50 Million | $-31.41 Million | -0.196x | +93.49% |
| 2022-12-31 | $58.59 Million | $-176.17 Million | -3.007x | -141.22% |
| 2021-12-31 | $237.15 Million | $-295.63 Million | -1.247x | -201.82% |
| 2020-12-31 | $519.35 Million | $-214.51 Million | -0.413x | +87.99% |
| 2019-12-31 | $38.62 Million | $-132.81 Million | -3.439x | +35.88% |
| 2018-12-31 | $24.04 Million | $-128.93 Million | -5.364x | -- |
| 2017-12-31 | $0.00 | $-93.76 Million | x | -- |
| 2016-12-31 | $0.00 | $-61.59 Million | x | -- |
| 2015-12-31 | $0.00 | $-44.69 Million | x | -- |
| 2014-12-31 | $0.00 | $-35.06 Million | x | -- |
| 2013-12-31 | $0.00 | $-10.82 Million | x | -- |
| 2012-12-31 | $15.55 Million | $-5.19 Million | -0.334x | -3613.31% |
| 2011-12-31 | $9.64 Million | $-86.58K | -0.009x | -102.45% |
| 2010-12-31 | $-5.36 Million | $-1.97 Million | 0.367x | +137.37% |
| 2009-12-31 | $-6.78 Million | $-1.05 Million | 0.155x | -84.76% |
| 2008-12-31 | $-4.38 Million | $-4.44 Million | 1.016x | -91.15% |
| 2007-12-31 | $-891.09K | $-10.23 Million | 11.480x | +322.86% |
| 2006-12-31 | $1.50 Million | $-7.75 Million | -5.151x | -686.97% |
| 2005-12-31 | $9.54 Million | $-6.24 Million | -0.655x | +48.77% |
| 2004-12-31 | $4.45 Million | $-5.69 Million | -1.278x | -152.94% |
| 2003-12-31 | $6.83 Million | $-3.45 Million | -0.505x | -111.53% |
| 2002-12-31 | $-326.99K | $-1.43 Million | 4.381x | +222.37% |
| 2001-12-31 | $1.25 Million | $-4.47 Million | -3.580x | -240.33% |
| 2000-12-31 | $1.10 Million | $-1.15 Million | -1.052x | -55.51% |
| 1999-12-31 | $3.40 Million | $-2.30 Million | -0.676x | -53.51% |
| 1998-12-31 | $5.90 Million | $-2.60 Million | -0.441x | +9.71% |
| 1997-12-31 | $8.40 Million | $-4.10 Million | -0.488x | +74.37% |
| 1996-12-31 | $2.10 Million | $-4.00 Million | -1.905x | -- |